Skip to main content Skip to footer
Oncidium Foundation
  • Contact us
  • 
  • 
  • 
  • 
  • 
  • About
    • About the foundation
    • Our ambassadors network
    • Our team
    • Oncidium in the USA
    • Our sponsors & partners
  • Our projects
    • RLT-Connect
    • Access
    • Education
    • Advocacy
    • Research
    • Impact Report
  • Patient information
    • Cancer Types
    • Clinical Trials
    • Patients Stories
  • Access treatment
    • Find a treatment center
    • Register your hospital
    • Treatment Donation Program
  • Radiotheranostics Resources
  • Media
    • Tackle Cancer Challenge
    • News & Events
    • Newsletters
    • Videos
    • Links
  • Donate
  • Contact us
  • About
    • About the foundation
    • Our ambassadors network
    • Our team
    • Oncidium in the USA
    • Our sponsors & partners
  • Our projects
    • RLT-Connect
    • Access
    • Education
    • Advocacy
    • Research
    • Impact Report
  • Patient information
    • Cancer Types
    • Clinical Trials
    • Patients Stories
  • Access treatment
    • Find a treatment center
    • Register your hospital
    • Treatment Donation Program
  • Radiotheranostics Resources
  • Media
    • Tackle Cancer Challenge
    • News & Events
    • Newsletters
    • Videos
    • Links
  • Donate

Radiotherapeutics

Lu-177-GD2-SADA-PRIT

Target/Mechanism
GD2
Carrier/Ligand
Small molecule
Radiation Type
beta (β–)
Back
Corporate Sponsors
Institutions & Programs Partners
RLT-Connect Partners
  • About
  • Patient support
  • Access treatment
  • Our ambassadors
  • Radiotheranostics Resources
  • Media
  • RLT-Connect
  • Donate
  • Contact
  • 
  • 
  • 
  • 
  • 

© 2026 | Oncidium foundation

  • Disclaimer
  • Privacy policy
  • Manage cookies
Newsletter
Latin American Nuclear Olympiad 2026 on Nuclear Medicine: RadiotheranosticsRead more
Nairobi Radiotheranostics Summit 2026Read more
#ASCO26 - Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing OncologistsRead more
TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225, Expanding Cancer Treatment AccessRead more
Virtual Radiotheranostics Summit: Expanding Access to Targeted Cancer Care Across AfricaRead more
